Please use this identifier to cite or link to this item:
|Title:||Immunomodulatory effects of G-CSF in cancer: Therapeutic implications.||Austin Authors:||Mouchemore, Kellie A;Anderson, Robin L||Affiliation:||Olivia Newton-John Cancer Research Institute
School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia;
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
|Issue Date:||Apr-2021||Date:||2021||Publication information:||Seminars in immunology 2021; 54: 101512||Abstract:||Numerous preclinical studies have reported a pro-tumour role for granulocyte colony-stimulating factor (G-CSF) that is predominantly mediated by neutrophils and MDSCs, the major G-CSF receptor expressing populations. In the presence of G-CSF (either tumour-derived or exogenous) these myeloid populations commonly exhibit a T cell suppressive phenotype. However, the direct effects of this cytokine on other immune lineages, such as T and NK cells, are not as well established. Herein we discuss the most recent data relating to the effect of G-CSF on the major immune populations, exclusively in the context of cancer. Recent publications have drawn attention to the other tumour-promoting effects of G-CSF on myeloid cells, including NETosis, promotion of cancer stemness and skewed differentiation of bone marrow progenitors towards myelopoiesis. Although G-CSF is safely and commonly used as a supportive therapy to prevent or treat chemotherapy-associated neutropenia in cancer patients, we also discuss the potential impacts of G-CSF on other anti-cancer treatments. Importantly, considerations for immune checkpoint blockade are highlighted, as many publications report a T cell suppressive effect of G-CSF that may diminish the effectiveness of this immunotherapy.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/29797||DOI:||10.1016/j.smim.2021.101512||ORCID:||0000-0002-6841-7422
|Journal:||Seminars in immunology||PubMed URL:||34763974||PubMed URL:||https://pubmed.ncbi.nlm.nih.gov/34763974/||Type:||Journal Article||Subjects:||Cancer
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 5, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.